Cambodia vs Kiribati: Cause of death, by non-communicable diseases, female
Cambodia
67.3%
in 2021
Kiribati
67.4%
in 2021
Cambodia rank
99th
Kiribati rank
98th
Cause of death, by non-communicable diseases, female over time
- Cambodia
- Kiribati
How they compare
Kiribati currently reports 67.4% against 67.3% in Cambodia, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kiribati ahead.
Cambodia ranks 99th and Kiribati ranks 98th of 185 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Kiribati in 2.
Head to head by decade
| Decade | Cambodia | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.9% | 61.1% | 20.1% | Kiribati |
| 2010s | 67.3% | 67.6% | 0.3% | Kiribati |
| 2020s | 70.3% | 68.1% | 2.2% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Cambodia or Kiribati?
- Kiribati, at 67.4% against 67.3% in Cambodia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Cambodia and Kiribati?
- 0.1%, with Kiribati ahead.
- How many years of comparable data are there for Cambodia and Kiribati?
- 6 years are reported by both, from 2000 to 2021.
- How do Cambodia and Kiribati rank globally for cause of death, by non-communicable diseases, female?
- Cambodia ranks 99th and Kiribati ranks 98th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.